Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physician Payment Disclosure Bill Should Include Other Entities – MedPAC

Executive Summary

The Medicare Payment Advisory Commission is recommending a more comprehensive system for reporting pharmaceutical industry payments than the one proposed in legislation pending before Congress

You may also be interested in...



Some Clouds For PhRMA In Sunshine Act: Revised Bill Loosens Pre-emption

Sens. Herb Kohl, D-Wis., and Chuck Grassley, R-Iowa, have narrowed state pre-emption provisions in their latest Physician Payments Sunshine Act

Some Clouds For PhRMA In Sunshine Act: Revised Bill Loosens Pre-emption

Sens. Herb Kohl, D-Wis., and Chuck Grassley, R-Iowa, have narrowed state pre-emption provisions in their latest Physician Payments Sunshine Act

Light from sunshine bill may reach more targets

Co-sponsors of the Physicians Payment Sunshine Act are discussing broadening its beam to cover more recipients of industry funding. Medicare Payment Advisory Commission has recommended that a public database include not only pharmaceutical and device company payments to physicians, but also to academic medical centers, continuing medical education organizations and patient and physician advocacy groups (1"The Pink Sheet," Sept. 8, 2008, p. 20). It is anticipated that CME providers will be covered when PPSA is reintroduced in 2009, according to a staffer at the Senate Aging Committee, whose chairman, Herb Kohl, D-Wis., co-authored the bill with Sen. Chuck Grassley, R-Iowa

Related Content

UsernamePublicRestriction

Register

PS050077

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel